bioMérieux mini VIDAS or HumaCLIA 150: Which Immunoassay Analyzer To Choose?

Chemiluminescence immunoassay (CLIA) analyzers such as the HumaCLIA 150 and mini VIDAS offer advanced features and capabilities to meet the diverse needs of today's diagnostic laboratories. Understanding the specific benefits of each model can help you select the optimal instrument for your laboratory's needs.

 

Company HUMAN bioMérieux
Model HumaCLIA 150 mini VIDAS
Type of Instrument Benchtop Benchtop
Mode Continuous access Batch mode
Detection based on Acridinium ester (AE) Fluorescence (FIA)
Throughput (up to) 150 t/h 80 t/h
Assay time approx. 30 min up to 90 minutes
Reagent positions 20 refrigerated 30
Sample positions 50 30
STAT positions (Emergency samples) 50 No
Reaction cuvettes onboard capacity 1000 cuvettes 30 strips
Cuvette format Single cuvettes in bulk format Reagent strip

*All information is correct as of March 2024

 

 

Selecting the right immunoassay analyzer can significantly enhance laboratory efficiency and accuracy. This comparison between the HUMAN HumaCLIA 150 and bioMérieux mini VIDAS highlights their key features to help you decide which one best meets your laboratory needs.

Detection based on

The detection method used in immunoassay analyzers significantly affects the sensitivity and specificity of the tests, impacting the accuracy and reliability of results. Here's a detailed look at the differences between Acridinium ester (AE) and Fluorescence (FIA) detection methods:

  • HumaCLIA 150:

    Acridinium Ester (AE) - AE is a chemiluminescent substrate used in immunoassays. When the acridinium ester-labeled antigen or antibody binds to its target, a chemical reaction is triggered. This reaction involves the oxidation of the acridinium ester, which produces light. The intensity of this light is measured and correlates directly with the amount of target substance present in the sample. AE-based detection is known for its high sensitivity and specificity, making it suitable for detecting low-abundance analytes. Key benefits include:

    • High Sensitivity: Capable of detecting very low levels of analytes, which is critical for assays requiring high precision.
    • High Specificity: Reduces the likelihood of cross-reactivity, ensuring accurate results.
    • Rapid Results: The chemiluminescent reaction is fast, allowing for quick turnaround times.
       
  • mini VIDAS:

    Fluorescence (FIA) - FIA uses fluorescence for detection, where the target antigen or antibody is labeled with a fluorescent dye. When the dye is excited by a light source, it emits light at a different wavelength. The emitted light is measured and correlates with the amount of target analyte. FIA is known for its versatility and broad application range. Key benefits include:

    • Versatility: Suitable for various types of immunoassays, providing flexibility in the types of tests that can be performed.
    • Stable Signal: Produces a stable and sustained signal, which can be advantageous for certain types of assays.
    • Cost-Effective: Often less expensive than chemiluminescent methods, making it accessible for many laboratories.

Throughput (up to)

Throughput capacity is crucial for laboratories with high sample volumes, as it determines the number of tests processed per hour, impacting overall efficiency and productivity.

  • HumaCLIA 150: Offers a maximum throughput of 150 tests per hour, ideal for high-volume testing environments.
  • mini VIDAS: Provides a throughput of 80 tests per hour, suitable for medium-volume laboratories.

Assay time

Assay time influences the speed at which individual tests are completed, affecting the turnaround time for results and overall laboratory workflow.

  • HumaCLIA 150: Has an approximate assay time of 30 minutes, providing a balance between rapid processing and detailed analysis.
  • mini VIDAS: Features an assay time of up to 90 minutes, which may be slower but allows for comprehensive analysis.

Reagent positions

The number of reagent positions is critical for laboratories conducting diverse tests, as it determines how many different assays can be run without frequent reagent changes.

  • HumaCLIA 150: Equipped with 20 refrigerated reagent positions, supporting a wide range of tests and minimizing reagent change frequency.
  • mini VIDAS: Offers 30 reagent positions, allowing for a broad range of assays and reducing the need for frequent changes.

Sample positions

Adequate sample positions are essential for managing sample volumes effectively, preventing backlogs, and ensuring smooth laboratory operations.

  • HumaCLIA 150: Provides 50 sample positions, catering to higher sample volumes and including provisions for urgent STAT samples.
  • mini VIDAS: Offers 30 sample positions, which may be sufficient for medium-volume laboratories.

STAT positions (Emergency samples)

Efficient handling of STAT (emergency) samples is vital for clinical laboratories, ensuring priority processing without disrupting routine workflows.

  • HumaCLIA 150: Integrates STAT sample handling within its 50 sample positions, allowing for seamless inclusion of urgent tests.
  • mini VIDAS: Does not offer dedicated STAT positions, which may be a limitation for laboratories requiring rapid emergency testing.

Reaction cuvettes onboard capacity

Onboard cuvette capacity is essential for ensuring the analyzer can handle a high number of reactions without frequent interruptions for reloading, thus supporting continuous and efficient workflow.

  • HumaCLIA 150: Has a capacity of 1000 cuvettes, supporting high-throughput operations.
  • mini VIDAS: Provides a capacity of 30 strips, which may require more frequent reloading compared to HumaCLIA 150.

Cuvette format

The format of the cuvettes impacts ease of handling and loading efficiency. This feature is vital for maintaining smooth operations and reducing the time needed for manual interventions.

  • HumaCLIA 150: Uses single cuvettes in bulk format, which facilitates easy handling and loading, contributing to efficient laboratory workflow.
  • mini VIDAS: Utilizes reagent strips, which can streamline the process but may require more handling compared to single cuvettes in bulk format.

Conclusion

The choice between the HumaCLIA 150 and mini VIDAS should be based on the specific priorities and requirements of your laboratory. Considerations include testing volume, reagent and sample capacity, STAT sample handling, assay time, and cuvette management. By evaluating these factors, laboratories can make a well-informed decision that aligns with their operational needs and testing demands.

 

Use the following form for any request whether it is product related or concerning potential distribution partnership.
Fields marked with a * are mandatory. Please take care in entering all data correctly.